![](/img/cover-not-exists.png)
Notification of suspected and unexpected serious adverse reactions according to the Clinical Trials Directive—A descriptive analysis of the legislation and the requirements in a European context
Larsen, Ellen Moseholm, Grarup, Jesper, Gey, Daniela Christine, Jensen, Karoline B., Kirk, OleVolume:
27
Language:
english
Journal:
Clinical Research and Regulatory Affairs
DOI:
10.3109/10601333.2010.507768
Date:
December, 2010
File:
PDF, 852 KB
english, 2010